LETTER AGREEMENTRetention Agreement • April 17th, 2006 • Britesmile Inc • Services-health services • Utah
Contract Type FiledApril 17th, 2006 Company Industry JurisdictionAs you know, BriteSmile, Inc. (the ‘Company”) has retained Piper Jaffrey as its investment banker to explore alternatives to enhance shareholder value. Such alternatives may involve a future sale of (i) all or substantially all of the assets of the Company or (ii) a controlling interest in the outstanding shares of common stock of the Company (a “Sale”).
LETTER AGREEMENTRetention Agreement • April 17th, 2006 • Britesmile Inc • Services-health services • Utah
Contract Type FiledApril 17th, 2006 Company Industry JurisdictionAs you know, BriteSmile, Inc. (the “Company”) has retained Piper Jaffrey as its investment banker to explore alternatives to enhance shareholder value. Such alternatives may involve a future sale of (i) all or substantially all of the assets of the Company or (ii) a controlling interest in the outstanding shares of common stock of the Company (a “Sale”).
LETTER AGREEMENTRetention Agreement • April 17th, 2006 • Britesmile Inc • Services-health services • Utah
Contract Type FiledApril 17th, 2006 Company Industry JurisdictionAs you know, BriteSmile, Inc. (the “Company”) has retained Piper Jaffrey as its investment banker to explore alternatives to enhance shareholder value. Such alternatives may involve a future sale of (i) all or substantially all of the assets of the Company or (ii) a controlling interest in the outstanding shares of common stock of the Company (a “Sale”).
LETTER AGREEMENTRetention Agreement • April 17th, 2006 • Britesmile Inc • Services-health services • Utah
Contract Type FiledApril 17th, 2006 Company Industry JurisdictionAs you know, BriteSmile, Inc. (the “Company”) has retained Piper Jaffrey as its investment banker to explore alternatives to enhance shareholder value. Such alternatives may involve a future sale of (i) all or substantially all of the assets of the Company or (ii) a controlling interest in the outstanding shares of common stock of the Company (a “Sale”).